Parkman Healthcare Partners LLC Entera Bio Ltd. Transaction History
Parkman Healthcare Partners LLC
- $678 Million
- Q2 2024
A detailed history of Parkman Healthcare Partners LLC transactions in Entera Bio Ltd. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 401,518 shares of ENTX stock, worth $738,793. This represents 0.11% of its overall portfolio holdings.
Number of Shares
401,518Holding current value
$738,793% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding ENTX
# of Institutions
17Shares Held
5.31MCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL3.88MShares$7.14 Million4.83% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY672KShares$1.24 Million0.01% of portfolio
-
Ubs Group Ag168KShares$308,4260.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny57.6KShares$105,9840.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA28.9KShares$53,0950.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $53M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...